This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jun;21(6):e297.

doi: 10.1016/S1470-2045(20)30283-7.

Knowing your tumour?

Ian F Tannock¹, John A Hickman²

Affiliations

Affiliations

¹ Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.
² Paris, France.

PMID: 32502449
DOI: 10.1016/S1470-2045(20)30283-7

Comment

Knowing your tumour?

Ian F Tannock et al. Lancet Oncol. 2020 Jun.

. 2020 Jun;21(6):e297.

doi: 10.1016/S1470-2045(20)30283-7.

Authors

Ian F Tannock¹, John A Hickman²

Affiliations

¹ Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.
² Paris, France.

PMID: 32502449
DOI: 10.1016/S1470-2045(20)30283-7

No abstract available

PubMed Disclaimer

Comment on

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, Bellakbira S, Thach D, Rahib L, Madhavan S, Matrisian LM, Petricoin EF 3rd. Pishvaian MJ, et al. Lancet Oncol. 2020 Apr;21(4):508-518. doi: 10.1016/S1470-2045(20)30074-7. Epub 2020 Mar 2. Lancet Oncol. 2020. PMID: 32135080 Free PMC article.

Similar articles

Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry.
Frere C, Trujillo-Santos J, Font C, Sampériz Á, Quintavalla R, González-Martínez J, Vázquez FJ, Lima J, Farge D, Monreal M; RIETE Investigators. Frere C, et al. Thromb Haemost. 2018 Jun;118(6):1119-1122. doi: 10.1055/s-0038-1642009. Epub 2018 Apr 21. Thromb Haemost. 2018. PMID: 29679948 No abstract available.
Knowing Your Boundaries: A Review of the Definitions and Imaging Features of Borderline Resectable Pancreatic Carcinoma.
McDonald N, Ahmad S, Ann Choe K. McDonald N, et al. Semin Roentgenol. 2016 Apr;51(2):82-7. doi: 10.1053/j.ro.2016.02.001. Epub 2016 Feb 2. Semin Roentgenol. 2016. PMID: 27105962 Review. No abstract available.
Precision oncology for pancreatic cancer in real-world settings.
Kleeff J, Michalski CW. Kleeff J, et al. Lancet Oncol. 2020 Apr;21(4):469-471. doi: 10.1016/S1470-2045(20)30148-0. Epub 2020 Mar 2. Lancet Oncol. 2020. PMID: 32135081 No abstract available.
Underutilization of surgical resection in patients with localized pancreatic cancer.
Riall TS, Lillemoe KD. Riall TS, et al. Ann Surg. 2007 Aug;246(2):181-2. doi: 10.1097/SLA.0b013e31811eaa2c. Ann Surg. 2007. PMID: 17667494 Free PMC article. No abstract available.
Adjuvant therapy for pancreatic adenocarcinoma.
Abrams RA. Abrams RA. J Gastrointest Surg. 2001 Jan-Feb;5(1):6-7. doi: 10.1016/s1091-255x(01)80003-2. J Gastrointest Surg. 2001. PMID: 11370618 Review. No abstract available.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information